🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 7 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/09/2021 83,93 85,85 83,58 85,63 +1,88% 2,70% 511.300
15/09/2021 82,50 84,55 80,68 84,05 +4,70% 4,69% 1.084.100
14/09/2021 81,65 82,32 80,10 80,28 -1,91% 2,72% 490.800
13/09/2021 80,94 82,83 79,95 81,84 +1,70% 3,56% 616.400
10/09/2021 80,67 82,15 79,75 80,47 -0,05% 2,98% 584.200
09/09/2021 78,48 80,99 78,18 80,51 +2,86% 3,58% 448.300
08/09/2021 78,29 78,67 77,17 78,27 -0,38% 1,92% 790.200
07/09/2021 80,75 82,25 78,28 78,57 -2,41% 4,92% 937.600
03/09/2021 79,49 80,85 79,03 80,51 +1,33% 2,29% 628.000
02/09/2021 79,56 79,90 77,77 79,45 +0,15% 2,68% 493.900
01/09/2021 78,12 81,25 78,06 79,33 +1,55% 4,08% 481.800
31/08/2021 76,10 79,65 76,10 78,12 +2,95% 4,66% 777.100
30/08/2021 78,18 78,94 75,35 75,88 -3,57% 4,59% 1.148.300
27/08/2021 78,10 80,33 77,26 78,69 +0,46% 3,93% 517.600
26/08/2021 79,92 80,72 78,06 78,33 -2,01% 3,33% 412.100
25/08/2021 77,16 81,03 76,38 79,94 +3,35% 6,03% 762.200
24/08/2021 73,66 77,79 73,05 77,35 +5,50% 6,43% 971.800
23/08/2021 75,89 76,70 73,02 73,32 -2,64% 4,85% 1.258.700
20/08/2021 73,77 76,50 73,77 75,31 +1,81% 3,70% 389.100
19/08/2021 74,32 75,22 73,07 73,97 -1,37% 2,89% 574.500
18/08/2021 78,02 78,40 74,92 75,00 -3,71% 4,46% 522.800
17/08/2021 75,39 77,91 75,23 77,89 +1,78% 3,55% 355.400
16/08/2021 79,31 79,31 76,22 76,53 -4,27% 3,90% 896.600
13/08/2021 80,78 81,50 79,39 79,94 -0,71% 2,61% 398.200
12/08/2021 80,77 81,76 80,09 80,51 -0,47% 2,07% 372.400
11/08/2021 79,91 81,70 78,69 80,89 +1,83% 3,77% 854.700
10/08/2021 78,24 79,52 76,79 79,44 +1,30% 3,49% 577.300
09/08/2021 79,49 81,78 78,33 78,42 -1,73% 4,34% 825.800
06/08/2021 78,07 80,11 76,50 79,80 +1,60% 4,62% 1.464.200
05/08/2021 71,75 79,80 71,71 78,54 +16,36% 11,28% 2.502.900